Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Tumori
|
September 18, 2010
Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer
Ali Osman Kaya, Suleyman Buyukberber, Faysal Dane, et al.
Onkologie
|
December 5, 2012
Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experience
Bulent Cetin, Mustafa Benekli, Berna Oksuzoglu, et al.
Oncology Letters
|
October 19, 2013
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience
Umut Kefeli, Mustafa Benekli, Alper Sevinc, et al.
Journal of Cancer Research and Clinical Oncology
|
August 11, 2012
Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer
Onder Tonyali, Ugur Coskun, Nur Sener, et al.
Onkologie
|
October 11, 2013
Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab
Onder Tonyali, Ugur Coskun, Nur Sener, et al.
Hepato-Gastroenterology
|
November 21, 2012
Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience
Umut Kefeli, Suleyman Buyuberber, Murat Akyol, et al.
Breast (Edinburgh, Scotland)
|
January 24, 2016
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
Onder Tonyali, Ugur Coskun, Sinemis Yuksel, et al.
Journal of Cancer Research and Clinical Oncology
|
February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)
Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Journal of Cancer Research and Clinical Oncology
|
December 3, 2013
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology
Ozge Gumusay, Ugur Coskun, Tülay Akman, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
November 22, 2012
Clinicopathological features in bilateral breast cancer
Meltem Baykara, Selcuk Cemil Ozturk, Suleyman Buyukberber, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Tumori
|
September 18, 2010
Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer
Ali Osman Kaya, Suleyman Buyukberber, Faysal Dane, et al.
Onkologie
|
December 5, 2012
Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experience
Bulent Cetin, Mustafa Benekli, Berna Oksuzoglu, et al.
Oncology Letters
|
October 19, 2013
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience
Umut Kefeli, Mustafa Benekli, Alper Sevinc, et al.
Journal of Cancer Research and Clinical Oncology
|
August 11, 2012
Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer
Onder Tonyali, Ugur Coskun, Nur Sener, et al.
Onkologie
|
October 11, 2013
Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab
Onder Tonyali, Ugur Coskun, Nur Sener, et al.
Hepato-Gastroenterology
|
November 21, 2012
Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience
Umut Kefeli, Suleyman Buyuberber, Murat Akyol, et al.
Breast (Edinburgh, Scotland)
|
January 24, 2016
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
Onder Tonyali, Ugur Coskun, Sinemis Yuksel, et al.
Journal of Cancer Research and Clinical Oncology
|
February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)
Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Journal of Cancer Research and Clinical Oncology
|
December 3, 2013
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology
Ozge Gumusay, Ugur Coskun, Tülay Akman, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
November 22, 2012
Clinicopathological features in bilateral breast cancer
Meltem Baykara, Selcuk Cemil Ozturk, Suleyman Buyukberber, et al.
Page
of 14